AlbugraninTM, a Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) Genetically Fused to Recombinant Human Albumin Induces Prolonged Myelopoietic Effects in Mice and Monkeys

[1]  N. Nicola.  Granulocyte Colony-Stimulating Factor , 2020, Colony-Stimulating Factors.

[2]  Bing Wang,et al.  Population Pharmacokinetic–Pharmacodynamic Modeling of Filgrastim (r-metHuG-CSF) in Healthy Volunteers , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[3]  B. Lord,et al.  Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  A. Ausema,et al.  Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony‐stimulating factor in mouse strains with distinct marrow‐cell pool sizes , 2000, British journal of haematology.

[5]  J. Crawford,et al.  Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  T. Inoue,et al.  Extended Activity in Cynomolgus Monkeys of a Granulocyte Colony‐Stimulating Factor Mutein Conjugated With High Molecular Weight Polyethylene Glycol , 2000, Stem cells.

[7]  T. Ulich,et al.  A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. , 1999, Experimental hematology.

[8]  J. Gabrilove,et al.  Filgrastim (r-metHuG-CSF): the first 10 years. , 1996, Blood.

[9]  M. Fukuda,et al.  Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts , 1996, Antimicrobial agents and chemotherapy.

[10]  Y. Sugiyama,et al.  Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): species differences among rats, monkeys and humans. , 1994, The Journal of pharmacology and experimental therapeutics.

[11]  D. Landais,et al.  Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Tanaka,et al.  Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in mice. , 1992, Blood.

[13]  J. Blay,et al.  Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  X. W. Liu,et al.  Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in rabbits and mice. , 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[15]  B. Raynor,et al.  Granulocyte colony-stimulating factor , 1995 .